RAD18 and neoplasm: To further confirm that RAD18-induced Hippo-YAP activation was a potent driving force for TNBC stemness maintenance, the shNC group was treated with a YAP-specific inhibitor verteporfin [26], and tumor sphere formation, stemness-related gene levels, and CD44+CD24− population percentage were then detected.